CYBIN INC. current report, Q2 FY2023

CYBIN INC. Form 6-K Summary

Business Context and Reporting Period

Cybin Inc. filed Form 6-K as a foreign private issuer for the month of June 2023. The filing was signed and dated June 5, 2023. The submission identifies the company’s principal executive offices in Toronto, Ontario.

The filing contains an exhibit index referencing Exhibit 99.1, a news release dated June 5, 2023. The text provided does not include the contents of that news release or describe the underlying business event.

Financial Metrics and Liquidity

The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, cash, liquidity, operating expenses, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide sufficient information to identify material changes versus a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not include management guidance, outlook, risk disclosures, contingencies, or unusual items. These matters may be addressed in the referenced news release, which is not included in the provided content.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the June 5, 2023 news release.
  • Verify whether the news release contains financial, clinical, regulatory, financing, or other material information.
  • Confirm any reported cash balance, financing activity, clinical-program update, guidance, or risk factors against the complete filing package.